Demographic and Pathological Features of 430 Cases of Lymphoma from a Tertiary Hospital in Seremban, Malaysia (2015-2022)

马来西亚芙蓉市一家三级医院430例淋巴瘤患者的人口统计学和病理学特征(2015-2022年)

阅读:2

Abstract

BACKGROUND: Lymphoma, including both Hodgkin and non-Hodgkin types, is the fourth most common cancer in Malaysia. Few large studies have examined the frequencies and patterns of occurrence. This study describes the epidemiology of lymphoma in Malaysia based on cases from a public hospital, and compares demographic characteristics, distribution, subtypes, and anatomical sites. METHODS: This retrospective study was conducted at Hospital Tuanku Ja'afar, Seremban, Malaysia. Admitted patients who had received medical or surgical treatment for lymphoma between 2015 and 2022 were reviewed. RESULTS: A total of 430 cases were recorded. The distribution between extranodal (52.1%) and nodal (46.0%) lymphoma was nearly equal. Hodgkin lymphoma (HL) accounted for 16.3% of cases, with a mean age at presentation of 37 years, compared with 55.7 years for non-Hodgkin lymphoma (NHL). Diffuse large B-cell lymphoma (DLBCL) was the most common NHL subtype, representing 44.2% of all lymphoma cases. Among patients with staging information, 63% were diagnosed at stage IV. Males comprised 61% of the population. The predominant ethnic group was Malay (70.2%). The largest age group was 60 to 69 years (32.2%). Follicular lymphoma occurred less frequently than in Western and other Asian countries but was more common among ethnic Indians in Malaysia. Primary mediastinal large B-cell lymphoma, like other large B-cell lymphomas, was more frequent among Malays. Ethnic Indians also showed higher rates of HL (30.7%) and lower rates of DLBCL (25.6%). CONCLUSION: This study highlights many similarities in the distribution of lymphoma in Malaysia compared with patterns observed in the region and globally.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。